Literature DB >> 29784146

Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.

Edward W Gregg1, Yiling J Cheng2, Meera Srinivasan2, Ji Lin2, Linda S Geiss2, Ann L Albright2, Giuseppina Imperatore2.   

Abstract

BACKGROUND: Large reductions in diabetes complications have altered diabetes-related morbidity in the USA. It is unclear whether similar trends have occurred in causes of death.
METHODS: Using data from the National Health Interview Survey Linked Mortality files from 1985 to 2015, we estimated age-specific death rates and proportional mortality from all causes, vascular causes, cancers, and non-vascular, non-cancer causes among US adults by diabetes status.
FINDINGS: From 1988-94, to 2010-15, all-cause death rates declined by 20% every 10 years among US adults with diabetes (from 23·1 [95% CI 20·1-26·0] to 15·2 [14·6-15·8] per 1000 person-years), while death from vascular causes decreased 32% every 10 years (from 11·0 [9·2-12·2] to 5·2 [4·8-5·6] per 1000 person-years), deaths from cancers decreased 16% every 10 years (from 4·4 [3·2-5·5] to 3·0 [2·8-3·3] per 1000 person-years), and the rate of non-vascular, non-cancer deaths declined by 8% every 10 years (from 7·7 [6·3-9·2] to 7·1 [6·6-7·5]). Death rates also declined significantly among people without diagnosed diabetes for all four major mortality categories. However, the declines in death rates were significantly greater among people with diabetes for all-causes (pinteraction<0·0001), vascular causes (pinteraction=0·0214), and non-vascular, non-cancer causes (pinteration<0·0001), as differences in all-cause and vascular disease death between people with and without diabetes were reduced by about a half. Among people with diabetes, all-cause mortality rates declined most in men and adults aged 65-74 years of age, and there was no decline in death rates among adults aged 20-44 years. The different magnitude of changes in cause-specific mortality led to large changes in the proportional mortality. The proportion of total deaths among adults with diabetes from vascular causes declined from 47·8% (95% CI 38·9-58·8) in 1988-94 to 34·1% (31·4-37·1) in 2010-15; this decline was offset by large increases in the proportion of deaths from non-vascular, non-cancer causes, from 33·5% (26·7-42·1) to 46·5% (43·3-50·0). The proportion of deaths caused by cancer was relatively stable over time, ranging from 16% to 20%.
INTERPRETATION: Declining rates of vascular disease mortality are leading to a diversification of forms of diabetes-related mortality with implications for clinical management, prevention, and disease monitoring. FUNDING: None.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29784146     DOI: 10.1016/S0140-6736(18)30314-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  108 in total

1.  Antidiabetic Medications and Mortality Risk in Individuals With Pancreatic Cancer-Related Diabetes and Postpancreatitis Diabetes: A Nationwide Cohort Study.

Authors:  Jaelim Cho; Robert Scragg; Stephen J Pandol; Mark O Goodarzi; Maxim S Petrov
Journal:  Diabetes Care       Date:  2019-06-21       Impact factor: 19.112

2.  Nephro Update Europe 2018.

Authors:  Nina Kesel
Journal:  Kidney Dis (Basel)       Date:  2019-04-26

3.  Physical Activity and Physical Function in Older Adults Living in a Retirement Community: A Cross-Sectional Analysis Focusing on Self-Rated Health.

Authors:  Emerson Sebastião; Shaine Henert; Vitor Antonio Assis Alves Siqueira
Journal:  Am J Lifestyle Med       Date:  2020-07-24

Review 4.  Global trends in diabetes complications: a review of current evidence.

Authors:  Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg
Journal:  Diabetologia       Date:  2018-08-31       Impact factor: 10.122

5.  Prospective associations of circulating adipocyte fatty acid-binding protein levels with risks of renal outcomes and mortality in type 2 diabetes.

Authors:  Chi Ho Lee; Chloe Y Y Cheung; Yu Cho Woo; David T W Lui; Michele M A Yuen; Carol H Y Fong; Wing Sun Chow; Amin Xu; Karen S L Lam
Journal:  Diabetologia       Date:  2018-09-28       Impact factor: 10.122

6.  Trends and Disparities in Cardiovascular Mortality Among U.S. Adults With and Without Self-Reported Diabetes, 1988-2015.

Authors:  Yiling J Cheng; Giuseppina Imperatore; Linda S Geiss; Sharon H Saydah; Ann L Albright; Mohammed K Ali; Edward W Gregg
Journal:  Diabetes Care       Date:  2018-08-21       Impact factor: 19.112

7.  Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.

Authors:  Qiuhong Gong; Ping Zhang; Jinping Wang; Jixiang Ma; Yali An; Yanyan Chen; Bo Zhang; Xinxing Feng; Hui Li; Xiaoping Chen; Yiling J Cheng; Edward W Gregg; Yinghua Hu; Peter H Bennett; Guangwei Li
Journal:  Lancet Diabetes Endocrinol       Date:  2019-04-26       Impact factor: 32.069

8.  Changing Disease Prevalence, Incidence, and Mortality Among Older Cohorts: The Health and Retirement Study.

Authors:  Eileen M Crimmins; Yuan S Zhang; Jung Ki Kim; Morgan E Levine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-11-13       Impact factor: 6.053

Review 9.  Beyond Statins: Who and When to Prescribe?

Authors:  Om Ganda
Journal:  Curr Diab Rep       Date:  2018-10-15       Impact factor: 4.810

10.  Tracking Anti-Staphylococcus aureus Antibodies Produced In Vivo and Ex Vivo during Foot Salvage Therapy for Diabetic Foot Infections Reveals Prognostic Insights and Evidence of Diversified Humoral Immunity.

Authors:  Irvin Oh; Gowrishankar Muthukrishnan; Mark J Ninomiya; James D Brodell; Benjamin L Smith; Charles C Lee; Steven R Gill; Christopher A Beck; Edward M Schwarz; John L Daiss
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.